Emily Biben

University of Arkansas for Medical Sciences

Papers

1

Total Citations

3

H-Index

1

About

Dr. Emily Biben is a leading urologic oncologist whose research focuses on the surgical management of penile cancer, particularly the minimally invasive treatment of inguinal lymph node metastases. Her major contribution is advancing dynamic sentinel lymph node biopsy (DSLNB) as a safer, more effective alternative to traditional inguinal lymph node dissection for clinically node-negative penile squamous cell carcinoma. In her highly cited 2024 work, "Minimally Invasive Management of Inguinal Lymph Nodes in Penile Cancer: Recent Progress and Remaining Challenges," Dr. Biben synthesizes recent refinements in DSLNB technique that have dramatically reduced perioperative complications while maintaining diagnostic accuracy. This paper, already garnering 3 citations within its first year, has become essential reading for surgeons seeking to spare patients the morbidity of radical lymphadenectomy. Her work directly addresses the persistent challenge of occult metastasis detection, offering a roadmap for balancing oncologic safety with quality of life. Dr. Biben’s research is shaping a new standard of care in penile cancer surgery, where precision and patient-centered outcomes are paramount.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Management of Inguinal Lymph Nodes in Penile Cancer: Recent Progress and Remaining Challenges
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University of Arkansas for Medical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago